The Effect of Probiotics on GI Symptoms

NCT ID: NCT03959722

Last Updated: 2020-09-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-19

Study Completion Date

2020-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A double-blind randomized, placebo-controlled study will be performed with experienced endurance athletes to assess the effect of probiotics supplementation on the occurrence and intensity of the gastrointestinal symptoms, on performance and on the composition and function of the gut microbiota. The duration of the supplementation period, with Ecologic® PERFORMANCE supplements, is fourteen weeks. Standardized maximum exercise tests on a treadmill are performed before and after the supplementation period, as well as two performance tests (before) and one performance test (after). During the performance tests, the load is first submaximal for 1 hour, after which a time trial of 30 minutes will be performed. The measurements before and after the supplementation period are performed on individual days with at least 48 hours of relative rest in between. During the supplementation period, training diaries, a Profile of Mood States (POMS) questionnaire and a few questionnaires about dietary habits will be completed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale: Endurance exercise, such as running a marathon, is becoming increasingly popular. In addition to the many positive health effects of endurance exercise, it can also be accompanied by gastrointestinal symptoms. For example, around 30-90% of runners suffer from gastrointestinal symptoms during or in the hours after intensive/endurance running. The occurrence of gastrointestinal symptoms is probably due to the redistribution of blood volume, resulting in less blood supply to the digestive tract and a less functioning intestinal barrier. Because the intestinal barrier functions less, endotoxins can enter the bloodstream and cause inflammatory reactions. Running in the heat causes extra redistribution of the blood volume, because extra blood is needed for cooling of the body. It is known that the gut microbiota affect food digestion, but also the functioning of the cells that line the intestinal wall and the connections between these cells. It is possible that runners with gastrointestinal symptoms face a different composition of the gut microbiota and / or metabolites during endurance exercise compared to runners without any complaints, as a result of which the gut barrier functions less well and problems may occur. Many positive effects have been attributed to the use of probiotics in general. Amongst which, the reduction of gastrointestinal symptoms during endurance exercise, probably due to improvement in intestinal permeability. Hence, the main goal of our research project is to investigate whether the chance of and/or intensity of gastrointestinal symptoms during endurance exercise and the exercise performance can be influenced by probiotics supplementation in trained endurance athletes. This will be studied in relation to the composition of the gut microbiota and / or metabolites.

Objective:

Primary Objective:

Can the chance at and/or intensity of gastrointestinal symptoms during exercise be influenced by probiotics supplementation in trained endurance athletes who experience these symptoms and can performance be enhanced? Secondairy Objective: Can the composition and function of the gut microbiota of trained athletes that experience gastrointestinal symptoms during exercise be positively influenced by probiotics supplementation?

Study design: A double-blind randomized placebo-controlled trial will be performed to investigate the effect of 14 weeks probiotics supplementation with Ecologic® PERFORMANCE supplements. Standardized maximal incremental exercise tests will be performed before and after the supplementation period, as well as two performance tests (before) and one performance test (after). During the supplementation period training diaries, a POMS questionnaire and some questionnaires about food habits will be completed, a food diary and Food Frequency Questionnaire (FFQ).

Study population: Healthy male endurance athletes of Dutch nationality, 18-45 years old, who regularly experience gastrointestinal symptoms during exercise.

Intervention: Fourteen weeks of supplementation with Ecologic® PERFORMANCE probiotics supplements (or placebo).

Main study parameters/endpoints: Main study endpoints are differences in changes in the severity and occurrence of gastrointestinal symptoms and changes in exercise performance (total distance on a time trial and maximum speed during an incremental exercise test). Also changes in composition of the microbiota and differences in changes in the metabolites in the stool sample before and after the supplementation period in the experimental and control group will be studied.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Benefits will be the value of the test results and outcome measures of the microbiome analysis. Also the chance on a reduced risk of occurrence of gastrointestinal symptoms might be of value for potential participants. The risks for the participants are minor. Only participants that are healthy and endurance trained will be included. In the Human Performance Laboratory of the Faculty of Behavioural and Human Movement Sciences, performance tests in warm conditions are executed regularly and health risks related to the experimental protocol are minor for the participants since they are already well-trained and the exercise intensity will be relatively well-tolerated, since they are used to similar efforts. Probiotics supplements are freely available at the market, and the Ecologic® PERFORMANCE supplements are available in the web shop of Winclove B.V. The same supplement has been used before in the same dosage and no adverse effects were reported. Participants will fill in a food frequency questionnaire and questionnaire about gastrointestinal symptoms and hand in a stool sample before and after the supplementation period. They will be asked to maintain a training diary during the supplementation period and also fill in the POMS questionnaire weekly. The maximal incremental exercise test (2 times) consists of a warming-up followed by incremental increase in running velocity until voluntary exhaustion. The performance tests (3 times) consists of 60 minutes of submaximal running followed by a time trial of 30 minutes in which participants need to accomplish as much distance as possible.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotics:Healthy male endurance athletes with GI symptoms

14 weeks of supplementation with a multispecies probiotics: Ecologic® PERFORMANCE ( 1\*1010 CFU(Colony forming units)/daily dose, Winclove Probiotics B.V., Amsterdam).

Group Type EXPERIMENTAL

Ecologic® PERFORMANCE

Intervention Type DIETARY_SUPPLEMENT

Ecologic® PERFORMANCE is a probiotic formulation consisting of different probiotic bacterial strains, namely:

Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Enterococcus faecium W54 Lactobacillus acidophilus W22 Lactobacillus brevis W63 Lactococcus lactis W58

Except for the bacterial strains, Ecologic® PERFORMANCE contains the following other ingredients:

* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)

Placebo: Healthy male endurance athletes with GI symptoms

14 weeks of supplementation with a placebo comparator (Winclove Probiotics B.V., Amsterdam)

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

The placebo contains no bacterial strains, but the following ingredients:

* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ecologic® PERFORMANCE

Ecologic® PERFORMANCE is a probiotic formulation consisting of different probiotic bacterial strains, namely:

Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Enterococcus faecium W54 Lactobacillus acidophilus W22 Lactobacillus brevis W63 Lactococcus lactis W58

Except for the bacterial strains, Ecologic® PERFORMANCE contains the following other ingredients:

* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)

Intervention Type DIETARY_SUPPLEMENT

Placebo

The placebo contains no bacterial strains, but the following ingredients:

* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Dutch nationality; maximal oxygen uptake (V ̇O\_2max) ≥ 45 mL·kg-1·min-1 (based on an incremental exercise test you are considered trained);
* an average training frequency of at least three times per week;
* a low risk profile based on a health-history form (the form is attached to the participant information letter);
* occurrence of exercise-induced gastrointestinal symptoms.

Exclusion Criteria

* smoking;
* a diagnosis of gastrointestinal disorders (e.g. Crohn's disease, celiac disease, diagnosed with irritable bowel syndrome);
* use of antidepressants in the 6 months prior to the start of the study;
* use of antibiotics, antivirals, antifungals, antiparasitic agents, prebiotics/probiotics supplements (foods are allowed) in the 6 months prior to the start of the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VU University of Amsterdam

OTHER

Sponsor Role collaborator

Wageningen University and Research

OTHER

Sponsor Role collaborator

Universiteit Leiden

OTHER

Sponsor Role collaborator

MyMicroZoo

UNKNOWN

Sponsor Role collaborator

Winclove Bio Industries BV

INDUSTRY

Sponsor Role collaborator

Karlijn te Poele

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Karlijn te Poele

MSc.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karlijn te Poele, MSc

Role: PRINCIPAL_INVESTIGATOR

Hogeschool Leiden, University of Applied Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vrije Universiteit Amsterdam

Amsterdam, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL69974.081.19

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.